METASTATIC ADRENAL GLAND PHEOCHROMOCYTOMA
Clinical trials for METASTATIC ADRENAL GLAND PHEOCHROMOCYTOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC ADRENAL GLAND PHEOCHROMOCYTOMA trials appear
Sign up with your email to follow new studies for METASTATIC ADRENAL GLAND PHEOCHROMOCYTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a Two-Drug combo slow rare adrenal cancers?
Disease control OngoingThis study tests whether adding olaparib to the standard chemotherapy drug temozolomide helps control advanced pheochromocytoma or paraganglioma, rare neuroendocrine tumors. About 46 adults with metastatic or inoperable disease will be randomly assigned to receive temozolomide al…
Matched conditions: METASTATIC ADRENAL GLAND PHEOCHROMOCYTOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 13, 2026 15:59 UTC
-
New hope for rare cancers: immune-boosting drug shows promise
Disease control OngoingThis study tests a drug called pembrolizumab in 157 people with rare tumors that cannot be removed by surgery or have spread. The drug helps the immune system fight cancer by blocking a protein that slows it down. The main goal is to see if the drug can stop tumors from growing f…
Matched conditions: METASTATIC ADRENAL GLAND PHEOCHROMOCYTOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 24, 2026 16:07 UTC